Asarina Pharma Year-End Report 2018 shows solid progress
Stockholm, 25 February, 2019: Asarina Pharma AB releases its Year-End Report including financials for the fourth quarter 2018 and for the full year 2018. (READ THE FULL YEAR-END REPORT IN PDF HERE .)Fourth Quarter 2018: FINANCIAL HIGHLIGHTS · Net sales amounted to 0 (0) kSEK · Operating loss was - – 20,481 (-7 364) kSEK · Loss per share, before dilution, SEK -0.88 (-0.45) · On 31 December 2018 Asarina had total cash and cash equivalents of 141